Arthur J. Gallagher & Co. (AJG)
(Delayed Data from NYSE)
$295.27 USD
+2.55 (0.87%)
Updated Nov 12, 2024 04:00 PM ET
After-Market: $295.40 +0.13 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Price, Consensus and EPS Surprise
AJG 295.27 +2.55(0.87%)
Will AJG be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for AJG based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AJG
ProAssurance Q3 Earnings Beat on Strong Net Investment Income
Top Analyst Reports for Oracle, Micron Technology & Medtronic
AJG: What are Zacks experts saying now?
Zacks Private Portfolio Services
PRA Group's Shares Up 17.8% Since Q3 Earnings Beat Estimates
MarketAxess Q3 Earnings Beat on Strong Credit Trading Volumes
Erie Indemnity Q3 Earnings Top on Higher Management Fee Revenues
Other News for AJG
FMR LLC Bolsters Stake in Arthur J. Gallagher & Co
Arthur J. Gallagher price target raised to $325 from $312 at BMO Capital
Arthur J. Gallagher price target raised by $13 at BMO Capital, here's why
Arthur J. Gallagher Reaches Analyst Target Price
Top Analyst Reports For Oracle, Micron Technology & Medtronic